Synonyms: Example 25 [WO2021087136A1] [ 1] | ORIC533
Comment: ORIC-533 is an orally bioavailable CD73 (Ecto-5'-Nucleotidase) inhibitor. Its chemical structure was revealed during the first time disclosures session at the 2024 ACS spring meeting in New Orleans. Multiple myeloma cells in the advanced disease stage have a high adenosine content, and this induces an immunosuppressive effect that shields the malignant cells from innate immune surveillance. CD73 inhibition blocks production of adenosine (from AMP) in multiple myeloma models and reverses the immunosuppressive action of adenosine.
|
|
2D Structure
|
|
Physico-chemical Properties
|
|
Hydrogen bond acceptors
|
18
|
Hydrogen bond donors
|
7
|
Rotatable bonds
|
12
|
Topological polar surface area
|
257.18
|
Molecular weight
|
605.93
|
XLogP
|
-2.28
|
No. Lipinski's rules broken
|
4
|
Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
|
SMILES / InChI / InChIKey
|
|
Canonical SMILES
|
C1CCC(C1)NC2=NC(=NC3=C2C=NN3[C@H]4[C@@H]([C@@H]([C@@H](CO[C@](CO)(COCC5=NNN=N5)P(=O)(O)O)O4)O)O)Cl
|
Isomeric SMILES
|
OC[C@](COCC1=NNN=N1)(OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N3N=CC4=C(NC5CCCC5)N=C(Cl)N=C34)P(O)(O)=O
|
InChI
|
InChI=1S/C20H29ClN9O9P/c21-19-24-16(23-10-3-1-2-4-10)11-5-22-30(17(11)25-19)18-15(33)14(32)12(39-18)6-38-20(8-31,40(34,35)36)9-37-7-13-26-28-29-27-13/h5,10,12,14-15,18,31-33H,1-4,6-9H2,(H,23,24,25)(H2,34,35,36)(H,26,27,28,29)/t12-,14-,15-,18-,20+/m1/s1
|
InChI Key
|
WQAMOSWUARUEOH-GGBXQBQZSA-N
|
Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
|
|